In the clinically evaluable population ( n = @ ) @ ( @ % ) of @ patients in the ceftaroline fosamil group and @ ( @ % ) of @ patients in the ceftriaxone group were clinically cured at the test-of-cure visit ( difference @ % , @ % CI @-@ ) .